Related Experiment Videos
Antimutagenicity of benzo[a]phenothiazines in chemically induced mutagenesis
1Faculty of Medicine, Institute of Microbiology, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Abstract:
Antipsychotic phenothiazines are known to have antimutagenic activities. The antimutagenicity of seven Benzo[a]phenothiazines was screened against Salmonella typhimurium strain TA98 treated with 4-nitro-o-phenylenediamine (4-NPD) which is a specific mutagen to this strain, and was compared to the antimutagenic activity of chlorpromazine, a 2-chlorphenothiazine derivative which has been shown to be the most effective mutagen inhibitor in the model. Benzo[a]phenothiazines are variously substituted by methyl-, oxo- and/or hydroxyl-substituent(s) at 5, 6, 9 and/or 10 positions(s). 9-Methyl-12H-benzo[a]phenothiazine [3] reduced the 4-NPD induced mutation by 30 percent, being a more potent antimutagenic agent than chlorpromazine. The study of antimutagenicity is of great interest in the development of cancer chemopreventive agents which halt cancer progression in multistage carcinogenesis, where successive mutation sequences are required to evolve into full-fledged metastatic cancer.
Insights
Seven benzo[a]phenothiazines were screened for antimutagenic activity. One compound, 9-methyl-12H-benzo[a]phenothiazine, showed significant antimutagenic effects against 4-nitro-o-phenylenediamine, outperforming chlorpromazine.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Toxicology
Background:
- Antipsychotic phenothiazines exhibit antimutagenic properties.
- Mutagenesis is a key process in multistage carcinogenesis.
- Antimutagenicity research is crucial for developing cancer chemopreventive agents.
Purpose of the Study:
- To screen the antimutagenicity of seven benzo[a]phenothiazines.
- To compare their efficacy against chlorpromazine, a known mutagen inhibitor.
- To identify potent antimutagenic compounds for potential cancer chemoprevention.
Main Methods:
- Screening of seven benzo[a]phenothiazines against Salmonella typhimurium strain TA98.
- Treatment with 4-nitro-o-phenylenediamine (4-NPD), a specific mutagen.
- Comparative analysis of antimutagenic activity with chlorpromazine.
Main Results:
- Benzo[a]phenothiazines were substituted at various positions (5, 6, 9, 10) with methyl, oxo, and/or hydroxyl groups.
- 9-Methyl-12H-benzo[a]phenothiazine demonstrated a 30% reduction in 4-NPD induced mutations.
- This compound exhibited superior antimutagenic potency compared to chlorpromazine.
Conclusions:
- 9-Methyl-12H-benzo[a]phenothiazine possesses significant antimutagenic activity.
- This finding supports the potential of benzo[a]phenothiazines as novel cancer chemopreventive agents.
- Further research into these compounds could advance cancer prevention strategies.